Trials / Completed
CompletedNCT01385202
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 172 (actual)
- Sponsor
- Biosense Webster, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the safety and effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheters with Contact Force Sensing Capability in the treatment of drug refractory symptomatic paroxysmal Atrial Fibrillation (AF) during standard electrophysiology mapping and RF procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | THERMOCOOL® SMARTTOUCH™ Catheter | AF Ablation |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2013-02-01
- Completion
- 2013-05-01
- First posted
- 2011-06-30
- Last updated
- 2025-02-04
- Results posted
- 2015-01-26
Source: ClinicalTrials.gov record NCT01385202. Inclusion in this directory is not an endorsement.